A Study of TEPEZZA Subcutaneous Administration in Healthy Adults
Status:
COMPLETED
Trial end date:
2021-05-27
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the pharmacokinetics (PK) parameters of a single subcutaneous (SubQ) infusion of TEPEZZA with and without ENHANZE™ Drug Product (EDP) at 2 dose levels in healthy adult participants.